P. V. Shimanov

Analysis of associations between pharmacodynamic genetic factors and antipsychotics’ effectiveness and safety in adolescents with acute psychotic episodes taking antipsychotics during a 28-day follow-up

E. Grishina, D. Sychev, D. V. Ivaschenko, 2021, Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice.

CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes

D. Ivashchenko, E. Grishina, D. Sychev, 2021, Drug metabolism and personalized therapy.

Associations of CYP2D6, ABCB1 2677G>T/A and 3435C>T with effectiveness and safety of pharmacotherapy for acute psychotic episodes in adolescents over 28 days

E. Grishina, D. Sychev, D. V. Ivaschenko, 2021, Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice.

CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes

D. Ivashchenko, E. Grishina, D. Sychev, 2021, Drug metabolism and personalized therapy.

Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation

D. Ivashchenko, E. Grishina, D. Sychev, 2020, Drug metabolism and personalized therapy.

The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study

D. Ivashchenko, E. Grishina, N. Buromskaya, 2020, Neurology, Neuropsychiatry, Psychosomatics.

Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode

D. Sychev, D. Ivashchenko, N. Buromskaya, 2019, V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY.